(Q47373508)

15 January 2018

title

(-)-Epigallocatechin-3-gallate inhibits pancreatic lipase and reduces body weight gain in high fat-fed obese mice (English)

1 reference

15 January 2018

0 references

1 reference

Kimberly A Grove

1

1 reference

15 January 2018

Sudathip Sae-tan

series ordinal

2

1 reference

15 January 2018

Mary J Kennett

series ordinal

3

1 reference

15 January 2018

Joshua D Lambert

series ordinal

4

1 reference

15 January 2018

publication date

2 June 2011

1 reference

15 January 2018

published in

Obesity

1 reference

15 January 2018

volume

20

1 reference

15 January 2018

issue

11

1 reference

15 January 2018

page(s)

2311-2313

1 reference

15 January 2018

Laboratory, epidemiological, and human intervention studies show that tea (Camellia sinensis) may be useful in the prevention of obesity

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.139

Effect of a thermogenic beverage on 24-hour energy metabolism in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.139

A green tea extract high in catechins reduces body fat and cardiovascular risks in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.139

TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.139

Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.139

Pancreatic lipase inhibitors from natural sources: unexplored potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.139

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.139

Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.139

Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.139

Green tea extract protects leptin-deficient, spontaneously obese mice from hepatic steatosis and injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.139

The role of pancreatic enzymes in digestion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.139

Tea catechins with a galloyl moiety suppress postprandial hypertriacylglycerolemia by delaying lymphatic transport of dietary fat in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.139

The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.139

Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.139

31 March 2020

Identifiers

DOI

10.1038/OBY.2011.139

1 reference

15 January 2018

1 reference

15 January 2018